AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%

AbbVie’s earnings topped estimates, and it offered an upbeat view of 2025.

Jan 31, 2025 - 08:00
 0  1
AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%
AbbVie’s earnings topped estimates, and it offered an upbeat view of 2025.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot